Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17931 (
galectin-3
)
2,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Galectin-3
, a multifunctional beta-galactoside-binding lectin, is known to participate in development, oncogenesis, cell-to-cell attachment, and inflammation. We studied to determine whether
galectin-3
is associated with cell injury and regeneration in two types of
acute renal failure
(
ARF
), namely ischemic and toxic
ARF
. In ischemia/reperfusion renal injury in rats (bilateral renal pedicles clamped for 40 minutes),
galectin-3
mRNA began to increase at 2 hours and extended by 6.2-fold at 48 hours (P: < 0.01 versus normal control rats), and then decreased by 28 days after injury. In addition, a significant negative correlation between
galectin-3
mRNA expression and serum reciprocal creatinine was shown at 48 hours after injury (n = 13, r = -0.94, P: < 0.0001). In folic acid-induced
ARF
,
galectin-3
mRNA was found to be up-regulated at 2 hours after injury and increased levels continued until at least 7 days post-injury. In immunohistochemistry, at 2 hours following reperfusion,
galectin-3
began to develop in proximal convoluted tubules. From 6 hours up to 48 hours,
galectin-3
was also found in proximal straight tubules, distal tubules, thick ascending limbs, and collecting ducts. In later stages of regeneration,
galectin-3
expressions were found in macrophages. In conclusion, we demonstrated that
galectin-3
expressions were markedly up-regulated in both ischemic and toxic types of
ARF
.
Galectin-3
may play an important role in acute tubular injury and the following regeneration stage.
...
PMID:Up-regulation of galectin-3 in acute renal failure of the rat. 1098 Jan 21